Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Pulmatrix, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q4 2022
- Shares held
- 511.8K
- −68.5K (−11.8%) vs. Q4 2022
- Total value
- $1.50M
- −$754.5K (−33.5%) vs. Q4 2022
- New holders
- 4
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PULM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $568.7K |
| Q1 2026 | 15 | $425.1K |
| Q4 2025 | 15 | $795.4K |
| Q3 2025 | 14 | $1.68M |
| Q2 2025 | 12 | $2.31M |
| Q1 2025 | 11 | $2.10M |
| Q4 2024 | 11 | $2.26M |
| Q3 2024 | 13 | $566.2K |
| Q2 2024 | 12 | $485.6K |
| Q1 2024 | 14 | $433.5K |
| Q4 2023 | 12 | $565.5K |
| Q3 2023 | 12 | $776.6K |
| Q2 2023 | 14 | $1.14M |
| Q1 2023 | 16 | $1.50M |
| Q4 2022 | 14 | $2.25M |
| Q3 2022 | 13 | $2.04M |
| Q2 2022 | 16 | $2.71M |
| Q1 2022 | 14 | $3.69M |
| Q4 2021 | 24 | $5.36M |
| Q3 2021 | 20 | $6.14M |
| Q2 2021 | 22 | $8.28M |
| Q1 2021 | 28 | $9.42M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Pulmatrix, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 220,029 | $642.5K | 2.39% | −81,914−27.1% | Reduced |
| Renaissance Technologies LLC | 105,620 | $308.0K | 0.00% | +1,500+1.4% | Added |
| BlackRock Inc. | 54,900 | $160.3K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 41,684 | $121.7K | 0.00% | −5,587−11.8% | Reduced |
| Susquehanna International Group, LLP | 24,907 | $73.5K | 0.00% | +24,907 | New |
| Geode Capital Management, LLC | 24,830 | $73.2K | 0.00% | −324−1.3% | Reduced |
| Citadel Advisors LLC | 15,174 | $44.8K | 0.00% | +15,174 | New |
| State Street Corp | 13,945 | $41.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,818 | $19.9K | 0.00% | +2,446+55.9% | Added |
| Tower Research Capital LLC (TRC) | 3,547 | $10.0K | 0.00% | +142+4.2% | Added |
| Advisor Group Holdings, Inc. | 201 | $587 | 0.00% | +100+99.0% | Added |
| Wells Fargo & Company | 25 | $73 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 25 | $73 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 5 | $15 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 3 | $9 | 0.00% | +3 | New |
| JPMorgan Chase & Co | 100 | $0 | 0.00% | +100 | New |
| Mariner, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −8−100.0% | Sold out |